Algert Global’s Mirum Pharmaceuticals MIRM Stock Holding History

Algert Global’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.95M	Buy	+33,700	New	+$3.38M	0.05%	622
2026 Q1	–	Sell	-174,189	Closed	-$13.8M	–	1267
2025 Q4	$13.8M	Sell	174,189 -16,410	-9%	-$1.18M	0.21%	119
2025 Q3	$14M	Buy	190,599 +31,250	+20%	+$1.99M	0.23%	102
2025 Q2	$8.11M	Buy	159,349 +92,588	+139%	+$4.12M	0.17%	184
2025 Q1	$3.01M	Sell	66,761 -1,530	-2%	-$72.1K	0.07%	462
2024 Q4	$2.82M	Buy	+68,291	New	+$2.85M	0.07%	493
2023 Q3	–	Sell	-25,940	Closed	-$671K	–	1198
2023 Q2	$671K	Buy	+25,940	New	+$690K	0.03%	748
2022 Q4	–	Sell	-22,805	Closed	-$479K	–	1221
2022 Q3	$479K	Sell	22,805 -3,365	-13%	-$81K	0.03%	817
2022 Q2	$509K	Buy	+26,170	New	+$617K	0.04%	752

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Algert Global's MIRM Position: Q2 2026 in Review

Algert Global opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 33,700 shares worth $3.95M. The stake represents 0.05% of the portfolio and ranks #622 among its holdings. This is a return to the name: Algert Global previously reported a position in MIRM as recently as Q4 2025.

Algert Global first reported a position in MIRM in Q2 2022 and has held it in 9 quarters since. The position peaked at $14M in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Algert Global held 33,700 shares of Mirum Pharmaceuticals worth $3.95M as of Q2 2026.
Mirum Pharmaceuticals was a new Algert Global position in Q2 2026.
Mirum Pharmaceuticals made up 0.05% of Algert Global's portfolio in Q2 2026, its #622 holding.
Algert Global first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 9 quarters since.
Algert Global's Mirum Pharmaceuticals position peaked at $14M in Q3 2025.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.